John F. Paolini, SVP & Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 63,444 shares at $18.91 ($1.2M) on 2020-02-20, disclosed to the SEC on 2020-02-21.
Open-market sale of $1.2M KNSA by SVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.27 | 22,477 | $411K | 35.1% |
| 2 | $18.27 | 22,477 | $411K | 35.1% |
| 3 | $18.91 | 8,687 | $164K | 14.0% |
| 4 | $18.91 | 8,687 | $164K | 14.0% |
| 5 | $19.32 | 1,116 | $22K | 1.8% |
| Total | $18.46 avg | 63,444 |
| $1.2M |
| 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |